WINTER SPRINGS, Fla., Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced FDA 510(k) clearance of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient vital ...
The Iradimed 3880 has a compact, lightweight design, allowing it to travel with the patient from their critical care unit to the MRI and back, resulting in increased patient safety through ...
IRadimed manufactures MRI products, including an MRI-compatible IV infusion pump system and patient vital signs monitoring system. The company has shown strong capabilities for innovation and has been ...
WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37 th Annual Roth Conference. IRADIMED ...
ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback